By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



12647 Alcosta Boulevard
Suite 400
San Ramon  California  94583   U.S.A.
Phone: 925-830-1000 Fax: 925-830-1002


Medical Device

Company News
BioVentrix Announces The 1st Revivent TC TransCatheter Ventricular Enhancement Procedure For Ischemic Cardiomyopathy Treatment In The Netherlands 11/21/2016 10:15:00 AM
Steven Healy Appointed As Chairman Of The Board Of Directors Of BioVentrix 10/4/2016 7:39:33 AM
BioVentrix Receives CE Marking Certification For Revivent TC, The First Minimally Invasive Heart Failure Treatment To Restore The Left Ventricle 6/27/2016 8:38:02 AM
BioVentrix Receives FDA IDE Approval For Its Pivotal Clinical Trial, ALIVE 5/31/2016 7:09:31 AM
BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure With Revivent-TC System For Heart Failure Treatment 5/16/2016 6:44:58 AM
BioVentrix Announces The 1st Revivent-TC Transcatheter Ventricular Enhancement Procedure For Ischemic Cardiomyopathy Treatment In The United Kingdom 2/23/2016 6:15:44 AM
BioVentrix Announces 30th Clinical Case Milestone For Revivent-TC Technology 12/14/2015 8:05:52 AM
BioVentrix Announces Milestone Achievement Of Its First Interventional Heart Failure Procedure For LV Volume Reduction In A Pre-Clinical Model 12/8/2015 9:23:19 AM
BioVentrix Raises $12 Million For Heart Attack Treatment 7/9/2014 9:34:16 AM
BioVentrix Cites Positive Media Coverage At Reuters TV 3/31/2014 11:08:39 AM